UNRESECTABLE ESOPHAGEAL CARCINOMA
Clinical trials for UNRESECTABLE ESOPHAGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE ESOPHAGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE ESOPHAGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug combo shows promise in Hard-to-Treat stomach cancer
Disease control CompletedThis study tested two drugs, olaparib and ramucirumab, together in 51 people with advanced stomach or gastroesophageal junction cancer that had spread or couldn't be removed. The goal was to find the safest dose and see if the combination helps shrink tumors or slow the disease. …
Matched conditions: UNRESECTABLE ESOPHAGEAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 03:30 UTC
-
Can a simple zinc pill ease the burden of cancer treatment?
Symptom relief CompletedThis study tested whether taking zinc supplements could improve quality of life for patients with upper gastrointestinal cancers who were receiving chemotherapy. Researchers wanted to see if preventing zinc deficiency might help patients feel better during treatment. The study in…
Matched conditions: UNRESECTABLE ESOPHAGEAL CARCINOMA
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Apr 17, 2026 16:11 UTC